At the nexus of commercial success and non-obviousness
Dr. Gregory K. Bell recently testified in three successful challenges to abbreviated new drug applications (ANDA) on behalf of pharmaceutical manufacturers...
Dr. Justin Ho is a principal in the Life Sciences Practice at CRA. He specializes in industrial organization and the economic and strategic evaluation of firm behavior and contracting.
Dr. Ho’s research includes the welfare and competitive effects of introducing new contracts between players in the video rental market and the optimal design of online feedback mechanisms. Since joining CRA, his projects include assisting counsel in breach of contract, antitrust, and intellectual property disputes, primarily in the pharmaceutical industry. He has also supported counsel on questions related to contract interpretation and damages assessment in these and other matters. In addition, Dr. Ho has advised pharmaceutical companies in pricing and other strategic matters.
Prior to joining CRA, Dr. Ho was an associate with Dean & Company where he worked on due diligence projects for a private equity client covering a range of industries including oil & gas, agriculture, consumer products, and manufacturing. He also assisted on projects for consumer products and health care technology companies in developing strategic plans.